News
Since the arrival of the San Fernando ship at the port on 11 July 2024, Vizhinjam has so far accommodated 392 vessels, ...
Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed ...
The second phase of the Western Ring Road project in Coimbatore is expected to begin soon, with the Tamil Nadu Highways ...
3h
Newspoint on MSNPhase-3 clinical trial enrolment for India’s first dengue vaccine to be completed by October: ICMREnrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed dengue vaccine, DengiAll, is likely to be completed by October across 20 ...
MiNK Therapeutics surged 730% on breakthrough testicular cancer data with agenT-797. Click here to read my analysis on INKT ...
An oral melanocortin-4 receptor agonist conferred significant BMI reductions among adolescents and adults with hypothalamic ...
Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity - ...
Nurix Therapeutics shows strong BTK degrader data and key pharma ties, with risks but solid long-term potential. Find out why ...
21h
Cyprus Mail on MSNInvestor alert: 72% of this new altcoin gone, will you miss the next 10x breakout?Are you going to buy when it’s already up 300%, or are you ready to enter before the next explosive run? That’s the question ...
Vizhinjam International Deepwater Multipurpose Seaport achieves full capacity, plans expansion to handle more cargo ...
Out of Rs 2,200 crore, around Rs 1,219 crore, will be invested to expand and modernise BITS campuses under Project Vistaar, ...
The one-shot vaccine, developed by Panacea Biotec and branded as DengiAll, is being tested through a multi-centre, double-blind, randomised, placebo-controlled trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results